论文部分内容阅读
目的:评价左卡尼汀对缺血性心脏病患者心力衰竭患者的临床疗效。方法:选取医院2013年8月—2015年12月期间收治的缺血性心脏病心力衰竭患者110例,将其随机分为观察组和对照组,每组55例;对照组患者给予常规治疗,观察组患者在对照组治疗的基础上加用左卡尼汀治疗,比较两组患者治疗后的总有效率和6 min步行(6 mWT)距离。结果:治疗前,两组患者的6 mWT距离经比较其差异无统计学意义(P>0.05),治疗后观察组患者的6 mWT距离和治疗的总有效率均优于对照组(P<0.05)。结论:左卡尼汀对缺血性心脏病患者心力衰竭有良好的临床疗效,可有效地改善了患者的心功能。
Objective: To evaluate the clinical efficacy of levocarnitine in patients with heart failure due to ischemic heart disease. Methods: A total of 110 patients with heart failure of ischemic heart disease admitted from August 2013 to December 2015 in our hospital were selected and randomly divided into observation group and control group, with 55 cases in each group. Patients in control group were given routine treatment, Patients in the observation group were treated with levocarnitine on the basis of the control group. The total effective rate and the distance of 6 mWT (6 mWT) after treatment were compared between the two groups. Results: Before treatment, there was no significant difference in the 6 mWT distance between the two groups (P> 0.05). After treatment, the 6 mWT distance and the total effective rate in the observation group were better than those in the control group (P <0.05 ). Conclusion: L-carnitine has a good clinical effect on heart failure in patients with ischemic heart disease, which can effectively improve the patient’s cardiac function.